Getting Personal with the VA
This article was originally published in RPM Report
Executive Summary
The VA pharmacy benefit offers a model for price negotiation under Medicare, but it is probably one that industry does not have to worry about too much. It sure helps when a former VA Secretary is on your side to make the case that the VA is not for everyone.
You may also be interested in...
Putting the Bully in the Bully Pulpit: The Democrats' Plan to Cut Drug Prices
Legislation to force price negotiation under Medicare Part D is likely to end in a stalemate. But manufacturers can't afford to relax: the Democrats plan to turn up the pressure even if a law never passes. First they will compare Part D prices to other benchmarks. Then the bullying begins.
US FDA Alzheimer Guidance Update Reflects Changes In Biomarkers – And Leadership
Latest update to draft guidance on early Alzheimer’s drug development is the third iteration of a document first published in 2013. The history of the guidance is a reflection of structural and leadership changes in the neurology review team at FDA.